Home > Authorities > Grants > Record #342499 > print

001     342499
005     20230827173352.0
024 7 _ |a G:(EU-Grant)190126414
|d 190126414
|2 CORDIS
024 7 _ |a G:(EU-Call)HORIZON-EIC-2023-ACCELERATOR-01
|d HORIZON-EIC-2023-ACCELERATOR-01
|2 CORDIS
024 7 _ |a corda_____he::190126414
|2 originalID
035 _ _ |a G:(EU-Grant)190126414
150 _ _ |a iLoF: AI-augmented photonics to identify and quantify disease biomarkers
|y 2023-08-01 - 2025-07-31
372 _ _ |a HORIZON-EIC-2023-ACCELERATOR-01
|s 2023-08-01
|t 2025-07-31
450 _ _ |a iLoF
|w d
|y 2023-08-01 - 2025-07-31
510 1 _ |0 I:(DE-588b)5098525-5
|a European Union
|2 CORDIS
680 _ _ |a iLoF is a digital health company pioneering a breakthrough AI-platform to accelerate the future of personalized drug discovery & development. Through advanced AI & photonics, we collect massive amounts of data to build a digital library of biomarkers & biological profiles, bringing together world-class physicists, biologists, & data scientists to get life-saving personalized treatments to patients faster. Our platform captures label-free patterns in biological liquid samples, to generate specific patient or disease signatures. The iLoF device generates multiple highly focused, non-destructive laser beams that interrogate the biological sample to obtain a digital signal of its light pattern. That signal is used to detect modifications providing a flexible & agnostic tool that is not limited to a single use or disease. The current project focuses on developing an Alzheimer’s disease (AD) clinical trial patient screening tool.
909 C O |o oai:juser.fz-juelich.de:1011858
|p authority:GRANT
|p authority
909 C O |o oai:juser.fz-juelich.de:1011858
980 _ _ |a G
980 _ _ |a CORDIS
980 _ _ |a AUTHORITY

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21